EMAIL THIS PAGE TO A FRIEND

International journal of pharmaceutics

Crystal face identification by Raman microscopy for assessment of crystal habit of a drug.


PMID 25615983

Abstract

Crystal habit is one of the key crystallographic characteristics of active pharmaceutical ingredients (APIs), especially those that are poorly soluble. X-ray powder diffraction has commonly been used to assess crystal habit; however, it can only provide macro-information regarding crystal habit for a whole powder sample, not for individual crystals. We describe an approach that uses Raman microscopy for the identification of crystal faces to assess crystal habit at the individual particle level. An antiepileptic agent, phenytoin, was used as the model substance. Phenytoin crystals form a primitive orthorhombic cell. Raman microscopy was used to identify three different patterns of Raman spectra, corresponding to the crystallographic axis that was parallel to the polarization direction of the excitation laser. Thus, a combination of Raman spectra, in which the polarization direction was horizontal and vertical to the morphologically long axis of the crystal, characterized the crystal face. Phenytoin crystals were prepared under various conditions, and the horizontal/vertical combinations of Raman spectra were recorded for individual crystals. The dominantly exposed crystal faces for each condition were identified. This analytical method enables micro-view assessments of crystal habit, which are helpful for identifying the habits of APIs alone and in formulations.